AllianceBernstein
OPTR

AllianceBernstein’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

AllianceBernstein’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-91,656
Closed -$1.16M – 3563
2013
Q3 		$1.16M Sell
91,656
-521,394
-85% -$6.91M ﹤0.01% 2052
2013
Q2 		$8.87M Buy
+613,050
New +$8.93M 0.01% 822

AllianceBernstein's OPTR Position: Q4 2013 in Review

AllianceBernstein sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 91,656 shares — an estimated $1.16M sold.

AllianceBernstein first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $8.87M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • AllianceBernstein reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • AllianceBernstein sold 91,656 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $1.16M.
  • AllianceBernstein first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • AllianceBernstein's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $8.87M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on AllianceBernstein's 13F filing for Q4 2013, filed 13 Feb 2014.